Drug Design Reviews - Online

Resistin: A Promising Therapeutic Target for the Management of Type 2 Diabetes Mellitus?
pp. 1-12(12)
Authors: Javier Gomez-Ambrosi; Gema Fruhbeck

Controlling Pathogenic Gram-Negative Bacteria by Interfering with Their Biofilm Formation
pp. 13-33(21)
Author: Wolf-Rainer Abraham

Drug Discovery: Methods for Identifying New Drug Targets
pp. 35-46(12)
Authors: Murty V. Chengalvala; Joshua E. Cottom; Linda K. Shanno; Gregory S. Kopf

Transforming Growth Factor-Beta: A Potential New Agent for Pleurodesis
pp. 47-51(5)
Authors: Ioannis Kalomenidis; Richard W. Light; Y C G. Lee

Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
pp. 53-65(13)
Authors: M. Wendeler; J. Wirtz; T. Kolter

Chimeric and Promiscuous G Proteins in Drug Discovery and the Deorphanization of GPCRs
pp. 66-79(14)
Authors: David C. New; Yung H. Wong

Cytotoxicity and Antiviral Activity of a Lignan Extracted from Larrea divaricata
pp. 81-83(3)
Authors: B. S. Konigheim; M. E. Goleniowski; M. S. Contigiani

Epigallocatechin-3-Gallate (EGCG): A Structural Target for the Development of Potential Therapeutic Drugs Against Anti-Proliferative Diseases
pp. 85-91(7)
Authors: Shiva P. Potta; Michael X.a.v.i.e.r. Doss; Jürgen Hescheler; Agapios Sachinidis

Author Index to Volume 1
pp. 93-94(2)
Author: Bentham Science Publishers

Subject Index to Volume 1
pp. 95-100(6)
Author: Bentham Science Publishers